Our findings suggested that HNRNPA2B1 acted by m6A-dependent modification of lncRNA MEG3, which acted as a sponge of miR-21-5p to regulate PTEN/PI3K/AKT signaling, contributing to NSCLC progression. Here, HNRNPA2B1 is linked to non-small cell lung carcinoma.